A meta-analysis of highly active anti-retroviral therapy for treatment of plasmablastic lymphoma

Hematology/ Oncology and Stem Cell Therapy

Volumn 3, Issue 1, 2010, Pages 7-12

  Guan, Bing ^a   Zhang, Xinhua ^a   Ma, Henhui ^a   Zhou, Hangbo ^a   Zhou, Xiaojun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

AIDS RELATED COMPLEX; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; EMBASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFORMATION RETRIEVAL; KAPLAN MEIER METHOD; MEDLINE; META ANALYSIS; PLASMABLASTIC LYMPHOMA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCISEARCH; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 77953656482     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1658-3876(10)50050-5     Document Type: Article

References (23)

1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H. Plasmablastic lymphomas of the oral caviity: a new entity associated with the human immunnodeficiency virus infection. Blood. 1997;89:1413-1420.
2. Kim JE, Kim YA, Kim WY, Kim CW, Ko YH, Lee GK, Choi SJ, Jeon YK. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma. 2009;50:582-587.
3. Kane S, Khurana A, Parulkar G, Shet T, Prabhash K, Nair R, Gujral S. Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a devveloping country. J Oral Pathol Med. 2009;38:138-144.
4. Bose P, Thompson C, Gandhi D, Ghabach B, Ozer H. AI DS-related plasmablastic lymphoma with dramatic, early response to bortezomib. Eur J Haematol. 2009;82:490-492.
5. Carbone A. AI DS-related non-Hodgkin's lymphommas: from pathology and molecular pathogenesis to treatment. Hum Pathol. 2002;33:392-404.
6. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis. 2009;15:38-45.
7. Dong HY, Scadden DT, de Leval L, Tang Z, Isaaccson PG, Harris NL. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neopplasm. Am J Surg Pathol. 2005;29:1633-1641.
8. Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V, Tirelli U, Dalla-Favera R, Gaidano G. Expression profile of MUM1/IR F4, BCL-6, and CD138/syndecan-1 defines novel histogennetic subsets of human immunodeficiency virusrelated lymphomas. Blood. 2001;97:744-751.
9. Carbone A, Gloghini A, Gaidano G. Is plasmabblastic lymphoma of the oral cavity an HHV-8-asssociated disease? Am J Surg Pathol. 2004;28:1538-1540; author reply 1540.
10. DerSimonian R, Laird N. Meta-analysis in cliniccal trials. Control Clin Trials. 1986;7:177-188.
11. Higgins JP, Thompson SG. Quantifying heteroggeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
12. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analysses. Ann Intern Med. 2001;135:982-989.
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessiing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
14. Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K. Plasmablastic lymphoma in HIV+ pattients: an expanding spectrum. Histopathology. 2003;42:605-609.
15. Cioc AM, Allen C, Kalmar JR, Suster S, Baioccchi R, Nuovo GJ. Oral plasmablastic lymphomas in AI DS patients are associated with human herpesvvirus 8. Am J Surg Pathol. 2004;28:41-46.
16. Folk GS, Abbondanzo SL, Childers EL, Foss RD. Plasmablastic lymphoma: a clinicopathologic corrrelation. Ann Diagn Pathol. 2006;10:8-12.
17. Gaidano G, Cerri M, Capello D, Berra E, Deambbrogi C, Rossi D, Larocca LM, Campo E, Gloghini A, Tirelli U, Carbone A. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-628.
18. Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, Redffield RR, Gilliam BL. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis. 2008;8:261-267.
19. Teruya-Feldstein J. Diffuse large B-cell lympphomas with plasmablastic differentiation. Curr Oncol Rep. 2005;7:357-363.
20. Castillo J, Pantanowitz L, Dezube BJ. HIVassociated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804-809.
21. Mani D, Guinee DG Jr, Aboulafia DM. AI DSassociated plasmablastic lymphoma presentiing as a poorly differentiated esophageal tumor: a diagnostic dilemma. World J Gastroenterol. 2008;14:4395-4399.
22. Goedhals J, Beukes CA, Hardie D. HHV8 in plasmablastic lymphoma. Am J Surg Pathol. 2008;32:172; author reply 172-174.
23. Carbone A, Gloghini A. Plasmablastic lympphoma: one or more entities? Am J Hematol. 2008;83:763-764.